\BOOKMARK [1][-]{section.1}{Introduction}{}% 1
\BOOKMARK [1][-]{section.2}{Deep MTB Drug Resistance Predictor \(DeepMDRP\)}{}% 2
\BOOKMARK [2][-]{subsection.2.1}{Network Architecture}{section.2}% 3
\BOOKMARK [2][-]{subsection.2.2}{Training and Testing}{section.2}% 4
\BOOKMARK [1][-]{section.3}{Experimental Details}{}% 5
\BOOKMARK [2][-]{subsection.3.1}{Dataset}{section.3}% 6
\BOOKMARK [2][-]{subsection.3.2}{Implementation Details}{section.3}% 7
\BOOKMARK [2][-]{subsection.3.3}{Ablation Studies}{section.3}% 8
\BOOKMARK [3][-]{subsubsection.3.3.1}{Choice of Models}{subsection.3.3}% 9
\BOOKMARK [3][-]{subsubsection.3.3.2}{Choice of Loss function}{subsection.3.3}% 10
\BOOKMARK [3][-]{subsubsection.3.3.3}{Dataset imbalance}{subsection.3.3}% 11
\BOOKMARK [3][-]{subsubsection.3.3.4}{Choice of Optimizer}{subsection.3.3}% 12
\BOOKMARK [3][-]{subsubsection.3.3.5}{Choice of Learning Rate Scheduler}{subsection.3.3}% 13
\BOOKMARK [3][-]{subsubsection.3.3.6}{Regularization strategies}{subsection.3.3}% 14
\BOOKMARK [3][-]{subsubsection.3.3.7}{Impact of transfer learning}{subsection.3.3}% 15
\BOOKMARK [3][-]{subsubsection.3.3.8}{Single-drug vs Multi-drug prediction}{subsection.3.3}% 16
\BOOKMARK [1][-]{section.4}{Final Performance}{}% 17
\BOOKMARK [1][-]{section.5}{Conclusion and Future Work}{}% 18
\BOOKMARK [1][-]{section.6}{Contributions}{}% 19
